-
psnet.ahrq.gov/node/47969/psn-pdf
June 12, 2019 - Nearly half of patients who had opioids suddenly
discontinued or with short tapering lengths experienced
-
psnet.ahrq.gov/web-mm/sudden-collapse-during-upper-gastrointestinal-endoscopy-expect-unexpected
September 25, 2024 - endoscopist were serially dilating the esophagus with larger and larger rigid dilators when the patient suddenly
-
psnet.ahrq.gov/issue/opioid-medication-discontinuation-and-risk-adverse-opioid-related-health-care-events
November 16, 2022 - Nearly half of patients who had opioids suddenly discontinued or with short tapering lengths experienced
-
psnet.ahrq.gov/issue/sudden-death-lung-embolism-after-inadvertent-infusion-zinc-oxide-shake-lotion
January 12, 2022 - Commentary
A sudden death with lung embolism after inadvertent infusion of zinc oxide shake lotion.
Citation Text:
Pragst F, Correns A, Priem F, et al. A sudden death with lung embolism after inadvertent infusion of zinc oxide shake lotion. Forensic Sci Int. 2007;170(2-3):207-12.
Cop…
-
psnet.ahrq.gov/node/37100/psn-pdf
October 04, 2011 - A sudden death with lung embolism after inadvertent
infusion of zinc oxide shake lotion.
October 4, 2011
Pragst F, Correns A, Priem F, et al. A sudden death with lung embolism after inadvertent infusion of zinc
oxide shake lotion. Forensic Sci Int. 2007;170(2-3):207-12.
https://psnet.ahrq.gov/issue/sudden-death-lu…
-
psnet.ahrq.gov/node/47754/psn-pdf
April 17, 2019 - FDA identifies harm reported from sudden
discontinuation of opioid pain medicines and requires
label changes to guide prescribers on gradual,
individualized tapering.
April 17, 2019
Silver Spring, MD: US Food and Drug Administration; April 9, 2019.
https://psnet.ahrq.gov/issue/fda-identifies-harm-reported-sudden-…
-
psnet.ahrq.gov/node/60185/psn-pdf
April 01, 2020 - Associations between stopping prescriptions for opioids,
length of opioid treatment, and overdose or suicide
deaths in US veterans: observational evaluation.
April 1, 2020
Oliva EM, Bowe T, Manhapra A, et al. Associations between stopping prescriptions for opioids, length of
opioid treatment, and overdose or suici…
-
psnet.ahrq.gov/node/867650/psn-pdf
January 01, 2022 - Opioid deprescribing toolkit.
January 1, 2022
Health Innovation East, National Health Service. Opioid deprescribing toolkit.
https://psnet.ahrq.gov/issue/opioid-deprescribing-toolkit
Sudden discontinuation of long-term prescription opioid use can lead to adverse outcomes for patients.
Based on research and clinici…
-
psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.206_slideshow.ppt
October 01, 2009 - Two days later, the patient suddenly arrested on the floor.
-
psnet.ahrq.gov/node/48091/psn-pdf
June 26, 2019 - Deprescribing Guidelines: Special Section on Symposium
Results.
June 26, 2019
Res Social Adm Pharm. 2019;15(6):780-810.
https://psnet.ahrq.gov/issue/deprescribing-guidelines-special-section-symposium-results
Appropriate deprescribing can reduce the risks associated with polypharmacy, overuse, and accidental
overd…
-
psnet.ahrq.gov/node/73621/psn-pdf
August 25, 2021 - Association of dose tapering with overdose or mental
health crisis among patients prescribed long-term
opioids.
August 25, 2021
Agnoli A, Xing G, Tancredi DJ, et al. Association of dose tapering with overdose or mental health crisis
among patients prescribed long-term opioids. JAMA. 2021;326(5):411-419. doi:10.100…
-
psnet.ahrq.gov/issue/fda-identifies-harm-reported-sudden-discontinuation-opioid-pain-medicines-and-requires-label
March 12, 2010 - Government Resource
FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering.
Citation Text:
FDA identifies harm reported from sudden discontinuation of opioid pain medicines and …
-
psnet.ahrq.gov/node/842764/psn-pdf
January 18, 2023 - Medication use evaluation of high-dose long-term opioid
de-prescribing in multiple Veterans Affairs medical
centers.
January 18, 2023
Barrett AK, Sandbrink F, Mardian A, et al. Medication use evaluation of high-dose long-term opioid de-
prescribing in multiple Veterans Affairs medical centers. J Gen Intern Med. 20…
-
psnet.ahrq.gov/node/73642/psn-pdf
August 25, 2021 - endoscopist were serially dilating the esophagus with larger and
larger rigid dilators when the patient suddenly
-
psnet.ahrq.gov/periodic-issue/periodic-issue-306
August 25, 2021 - endoscopist were serially dilating the esophagus with larger and larger rigid dilators when the patient suddenly
-
psnet.ahrq.gov/node/36288/psn-pdf
December 23, 2016 - Preventing adverse events caused by emergency
electrical power system failures.
December 23, 2016
Preventing adverse events caused by emergency electrical power system failures. Sentinel Event Alert.
2006;37(37):1-3.
https://psnet.ahrq.gov/issue/preventing-adverse-events-caused-emergency-electrical-power-system-
…
-
psnet.ahrq.gov/sites/default/files/2024-08/spotlight_case_a_fatal_twist_in_pseudohyperkalemia_slides.pptx
January 01, 2024 - Spotlight
Spotlight
A Fatal Twist in Pseudohyperkalemia
1
Source and Credits
This presentation is based on the August 2024 AHRQ WebM&M Spotlight Case
See the full article at https://psnet.ahrq.gov/webmm
CME credit is available
Commentary by: Justin L. Devera, MD, David K. Barnes, MD, FACEP, and William R. Le…
-
psnet.ahrq.gov/issue/fentora-fentanyl-buccal-tablet
October 28, 2020 - Government Resource
Fentora (fentanyl buccal tablet).
Save
Print
Share
Facebook
Twitter
Linkedin
Copy URL
September 26, 2007
This announcement provides specific instructions on safe prescribing of a cancer pain…
-
psnet.ahrq.gov/node/33875/psn-pdf
March 01, 2019 - So suddenly the
formulary changes, some biomedical equipment changes, a test or radiology reporting … Suddenly, there are a lot of patients with opioid use disorder or non-
English speaking patients.
-
psnet.ahrq.gov/issue/fda-preliminary-public-health-notification-update-information-about-ralstonia-spp-associated
April 17, 2019 - Government Resource
FDA preliminary public health notification: update of information about Ralstonia spp. associated with Vapotherm Respiratory Gas Administration device.
Citation Text:
Food and Drug Administration; FDA.
Copy Citation
Save
Print
…